159 related articles for article (PubMed ID: 29581864)
1. Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy.
Bustos SO; da Silva Pereira GJ; de Freitas Saito R; Gil CD; Zanatta DB; Smaili SS; Chammas R
Oncotarget; 2018 Mar; 9(18):14567-14579. PubMed ID: 29581864
[TBL] [Abstract][Full Text] [Related]
2. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells.
Martin S; Dudek-Perić AM; Maes H; Garg AD; Gabrysiak M; Demirsoy S; Swinnen JV; Agostinis P
Biochem Pharmacol; 2015 Feb; 93(3):290-304. PubMed ID: 25529535
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E-dependent role of autophagy in uveal melanoma.
Zhao Y; Wang W; Min I; Wyrwas B; Moore M; Zarnegar R; Fahey TJ
J Cancer Res Clin Oncol; 2017 Mar; 143(3):447-455. PubMed ID: 27928645
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma.
Corazzari M; Rapino F; Ciccosanti F; Giglio P; Antonioli M; Conti B; Fimia GM; Lovat PE; Piacentini M
Cell Death Differ; 2015 Jun; 22(6):946-58. PubMed ID: 25361077
[TBL] [Abstract][Full Text] [Related]
5. Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma.
Krayem M; Najem A; Journe F; Morandini R; Sales F; Awada A; Ghanem GE
Oncotarget; 2018 Aug; 9(61):31888-31903. PubMed ID: 30159130
[TBL] [Abstract][Full Text] [Related]
6. Vemurafenib.
Garbe C; Abusaif S; Eigentler TK
Recent Results Cancer Res; 2014; 201():215-25. PubMed ID: 24756795
[TBL] [Abstract][Full Text] [Related]
7. Vemurafenib in patients with BRAF V600E mutation-positive advanced melanoma.
Ravnan MC; Matalka MS
Clin Ther; 2012 Jul; 34(7):1474-86. PubMed ID: 22742884
[TBL] [Abstract][Full Text] [Related]
8. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.).
Jang GH; Lee M
Life Sci; 2014 Apr; 102(1):41-8. PubMed ID: 24625733
[TBL] [Abstract][Full Text] [Related]
9. Involvement of superoxide and nitric oxide in BRAF(V600E) inhibitor PLX4032-induced growth inhibition of melanoma cells.
Yu L; Gao LX; Ma XQ; Hu FX; Li CM; Lu Z
Integr Biol (Camb); 2014 Dec; 6(12):1211-7. PubMed ID: 25363644
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline triggers autophagy via ER stress response that interferes with Pentoxifylline induced apoptosis in human melanoma cells.
Sharma K; Ishaq M; Sharma G; Khan MA; Dutta RK; Majumdar S
Biochem Pharmacol; 2016 Mar; 103():17-28. PubMed ID: 26793997
[TBL] [Abstract][Full Text] [Related]
11. BRAF-mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib.
Nagasawa I; Kunimasa K; Tsukahara S; Tomida A
Biochem Biophys Res Commun; 2017 Jan; 482(4):1491-1497. PubMed ID: 27965097
[TBL] [Abstract][Full Text] [Related]
12. Cumingianoside A, a Phyto-Triterpenoid Saponin Inhibits Acquired BRAF Inhibitor Resistant Melanoma Growth via Programmed Cell Death.
Cvetanova B; Shen YC; Shyur LF
Front Pharmacol; 2019; 10():30. PubMed ID: 30745871
[TBL] [Abstract][Full Text] [Related]
13. Targeting autophagy as a potential therapeutic approach for melanoma therapy.
Liu H; He Z; Simon HU
Semin Cancer Biol; 2013 Oct; 23(5):352-60. PubMed ID: 23831275
[TBL] [Abstract][Full Text] [Related]
14. ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation.
Peng U; Wang Z; Pei S; Ou Y; Hu P; Liu W; Song J
Oncol Rep; 2017 Feb; 37(2):1270-1276. PubMed ID: 28035401
[TBL] [Abstract][Full Text] [Related]
15. Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro.
Maes H; Martin S; Verfaillie T; Agostinis P
Exp Dermatol; 2014 Feb; 23(2):101-6. PubMed ID: 24313465
[TBL] [Abstract][Full Text] [Related]
16. Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.
Rizzolio S; Corso S; Giordano S; Tamagnone L
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784465
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 Expression in Pancreatic Cell Lines Under Distinct Autophagy-Inducing Stimulus.
da Silva Filho AF; de Sousa LM; Consonni SR; da Rocha Pitta MG; Carvalho HF; de Melo Rêgo MJB
Microsc Microanal; 2020 Dec; 26(6):1187-1197. PubMed ID: 33107424
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of autophagic flux by ROS promotes apoptosis during DTT-induced ER/oxidative stress in HeLa cells.
Xiang XY; Yang XC; Su J; Kang JS; Wu Y; Xue YN; Dong YT; Sun LK
Oncol Rep; 2016 Jun; 35(6):3471-9. PubMed ID: 27035858
[TBL] [Abstract][Full Text] [Related]
19. Chk1 inhibition as a novel therapeutic strategy in melanoma.
Hwang BJ; Adhikary G; Eckert RL; Lu AL
Oncotarget; 2018 Jul; 9(54):30450-30464. PubMed ID: 30100999
[TBL] [Abstract][Full Text] [Related]
20. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
